The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation
- 1 January 1989
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 24 (5) , 329-331
- https://doi.org/10.1007/bf00304768
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- High-performance liquid chromatography of etoposide in plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Lack of effect of ibopamine, a dopamine pro-drug, on renal function in normal subjects.British Journal of Clinical Pharmacology, 1984
- STRIPE: An interactive computer program for the analysis of drug pharmacokineticsJournal of Pharmacological Methods, 1983
- VP16-213 (Etoposide)Cancer Chemotherapy and Pharmacology, 1982
- VP-16-213 (etoposide): The mandrake root from Issyk-KulThe American Journal of Medicine, 1982
- ETOPOSIDE: A NEW ANTI-CANCER AGENTThe Lancet, 1981
- The Epipodophyllotoxin Derivatives VM-26 and VP-16-213, 1976–1979, a ReviewPublished by Springer Nature ,1980
- Etoposide (VP-16-213)Cancer Treatment Reviews, 1979
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsPublished by Elsevier ,1973
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948